IN studies on the mechanism of the coagulation of blood, I have found that an active principle of coagulation is formed in the process of coagulation—a principle which can be transferred indefinitely ...

Researchers have developed synthetic platelets from biodegradable polymers. In animal models, the synthetics attach to natural platelets and stem bleeding faster than current treatments. Blood loss is ...

Blood clotting is a complex cascade of events that works well for normal cuts and scrapes, however, more serious injuries can overwhelm the body’s natural blood-clotting process. With traumatic injury ...

People who are using blood-thinning medications regularly have to check if their dosage needs adjusting. And while doing so currently involves lab tests or expensive home systems, a simple ...

Thirteen patients with liver disease and an abnormal prothrombin time refractory to vitamin K therapy were studied (Tables 1 and 2). None of the patients were actively bleeding, and none had received ...

In patients with NSTE-ACS on heparin monotherapy during PCI, lower activated clotting time (ACT) values do not predict bleeding events but do correlate with higher risk of ischemic events, according ...

Scientists have discovered three genes that could shed light on the genetic causes of blood-clotting disorders such as thrombosis and some types of stroke. Scientists have discovered three genes that ...

When a blood vessel is damaged, your body naturally responds to stop bleeding and loss of blood. Hemostasis or stoppage of bleeding occurs in three steps blood vessel constriction, platelet plug ...

Specific reversal agents for non–vitamin K antagonist oral anticoagulants are lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran. We ...

Hematologists have long sought ways to prevent the formation of dangerous and possibly fatal blood clots. First there was heparin, extracted from the livers and lungs of beef cattle. Then came ...